While many of Donald Trump’s executive orders have been radical and controversial, the president’s latest order was the sort of move that has few critics. USA Today reported: In the Republican’s first ...

The order itself has virtually no legal effect, but it could become a dangerously effective tool for Trump’s campaign of vengeance against his perceived enemies. In a normal world, President Trump’s ...

University of Southern California professor Helen Choi had a pretty basic assignment for her students this fall: Read a book. To be sure, Choi’s pedagogical choice isn’t novel for many faculty; 71 ...

President Trump signed an executive order on Tuesday aimed at using artificial intelligence to improve research and treatments for childhood cancer. The order builds on a 2019 database established by ...

With the 2025 MLB regular season complete, we have a clearer picture of the lottery odds for the 2026 draft. Since 2023, the MLB Draft has been determined by a lottery that includes each of the 18 ...

The Supreme Court on Wednesday dismissed a plea filed by UK-based fashion brand Lifestyle Equities CV challenging the stay imposed by the Delhi High Court Division Bench on an order directing Amazon ...

HALIFAX - A significant cut to Nova Scotia’s home heating program was called out by the Opposition NDP leader on Wednesday, who said 46,000 fewer households are eligible for the rebate this year.

Anchorage police officers will soon be able to automatically scan license plates and scour a network of public and private cameras throughout the city. The expansion into additional surveillance is ...

The federal funding, although significant, will only partially offset the impending cuts to Medicaid spending that Congress approved this year New Hampshire leaders are asking the state’s rural health ...

HARNESSING AMERICAN AI INNOVATION: Today, President Donald J. Trump signed an Executive Order to harness American AI innovation to unlock cures and prevention strategies for pediatric cancer, and ...

It was only about a year ago that the biopharma industry hailed a decision by the Supreme Court to preserve access to mifepristone, a drug most commonly known for its paired use with another medicine ...